TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Boehringer Ingelheim (Canada)
Boehringer Ingelheim (Canada)
Affinity DataIC50: 1.90nMpH: 5.5 T: 2°CAssay Description:Sensitivity of HIV-1 protease activity to protease inhibitors was determined by a peptide substrate cleavage assay. Cleavage products and substrate w...More data for this Ligand-Target Pair
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Boehringer Ingelheim (Canada)
Boehringer Ingelheim (Canada)
Affinity DataIC50: 2.20nMpH: 5.5 T: 2°CAssay Description:Sensitivity of HIV-1 protease activity to protease inhibitors was determined by a peptide substrate cleavage assay. Cleavage products and substrate w...More data for this Ligand-Target Pair
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Boehringer Ingelheim (Canada)
Boehringer Ingelheim (Canada)
Affinity DataIC50: 2.20nMpH: 5.5 T: 2°CAssay Description:Sensitivity of HIV-1 protease activity to protease inhibitors was determined by a peptide substrate cleavage assay. Cleavage products and substrate w...More data for this Ligand-Target Pair
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Boehringer Ingelheim (Canada)
Boehringer Ingelheim (Canada)
Affinity DataIC50: 2.5nMpH: 5.5 T: 2°CAssay Description:Sensitivity of HIV-1 protease activity to protease inhibitors was determined by a peptide substrate cleavage assay. Cleavage products and substrate w...More data for this Ligand-Target Pair
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Boehringer Ingelheim (Canada)
Boehringer Ingelheim (Canada)
Affinity DataIC50: 2.90nMpH: 5.5 T: 2°CAssay Description:Sensitivity of HIV-1 protease activity to protease inhibitors was determined by a peptide substrate cleavage assay. Cleavage products and substrate w...More data for this Ligand-Target Pair
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Boehringer Ingelheim (Canada)
Boehringer Ingelheim (Canada)
Affinity DataIC50: 3nMpH: 5.5 T: 2°CAssay Description:Sensitivity of HIV-1 protease activity to protease inhibitors was determined by a peptide substrate cleavage assay. Cleavage products and substrate w...More data for this Ligand-Target Pair
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Boehringer Ingelheim (Canada)
Boehringer Ingelheim (Canada)
Affinity DataIC50: 3nMpH: 5.5 T: 2°CAssay Description:Sensitivity of HIV-1 protease activity to protease inhibitors was determined by a peptide substrate cleavage assay. Cleavage products and substrate w...More data for this Ligand-Target Pair
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Boehringer Ingelheim (Canada)
Boehringer Ingelheim (Canada)
Affinity DataIC50: 3.60nMpH: 5.5 T: 2°CAssay Description:Sensitivity of HIV-1 protease activity to protease inhibitors was determined by a peptide substrate cleavage assay. Cleavage products and substrate w...More data for this Ligand-Target Pair
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Boehringer Ingelheim (Canada)
Boehringer Ingelheim (Canada)
Affinity DataIC50: 3.80nMpH: 5.5 T: 2°CAssay Description:Sensitivity of HIV-1 protease activity to protease inhibitors was determined by a peptide substrate cleavage assay. Cleavage products and substrate w...More data for this Ligand-Target Pair
TargetDimer of Gag-Pol polyprotein [514-612](Human immunodeficiency virus type 2)
Boehringer Ingelheim (Canada)
Boehringer Ingelheim (Canada)
Affinity DataIC50: 6.30nMpH: 5.5 T: 2°CAssay Description:Sensitivity of HIV-1 protease activity to protease inhibitors was determined by a peptide substrate cleavage assay. Cleavage products and substrate w...More data for this Ligand-Target Pair
TargetDimer of Gag-Pol polyprotein [514-612](Human immunodeficiency virus type 2)
Boehringer Ingelheim (Canada)
Boehringer Ingelheim (Canada)
Affinity DataIC50: 6.70nMpH: 5.5 T: 2°CAssay Description:Sensitivity of HIV-1 protease activity to protease inhibitors was determined by a peptide substrate cleavage assay. Cleavage products and substrate w...More data for this Ligand-Target Pair
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Boehringer Ingelheim (Canada)
Boehringer Ingelheim (Canada)
Affinity DataIC50: 8.20nMpH: 5.5 T: 2°CAssay Description:Sensitivity of HIV-1 protease activity to protease inhibitors was determined by a peptide substrate cleavage assay. Cleavage products and substrate w...More data for this Ligand-Target Pair
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Boehringer Ingelheim (Canada)
Boehringer Ingelheim (Canada)
Affinity DataIC50: 14nMpH: 5.5 T: 2°CAssay Description:Sensitivity of HIV-1 protease activity to protease inhibitors was determined by a peptide substrate cleavage assay. Cleavage products and substrate w...More data for this Ligand-Target Pair
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Boehringer Ingelheim (Canada)
Boehringer Ingelheim (Canada)
Affinity DataIC50: 15nMpH: 5.5 T: 2°CAssay Description:Sensitivity of HIV-1 protease activity to protease inhibitors was determined by a peptide substrate cleavage assay. Cleavage products and substrate w...More data for this Ligand-Target Pair
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Boehringer Ingelheim (Canada)
Boehringer Ingelheim (Canada)
Affinity DataIC50: 19nMpH: 5.5 T: 2°CAssay Description:Sensitivity of HIV-1 protease activity to protease inhibitors was determined by a peptide substrate cleavage assay. Cleavage products and substrate w...More data for this Ligand-Target Pair
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Boehringer Ingelheim (Canada)
Boehringer Ingelheim (Canada)
Affinity DataIC50: 19nMpH: 5.5 T: 2°CAssay Description:Sensitivity of HIV-1 protease activity to protease inhibitors was determined by a peptide substrate cleavage assay. Cleavage products and substrate w...More data for this Ligand-Target Pair
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Boehringer Ingelheim (Canada)
Boehringer Ingelheim (Canada)
Affinity DataIC50: 25nMpH: 5.5 T: 2°CAssay Description:Sensitivity of HIV-1 protease activity to protease inhibitors was determined by a peptide substrate cleavage assay. Cleavage products and substrate w...More data for this Ligand-Target Pair
TargetDimer of Gag-Pol polyprotein [514-612](Human immunodeficiency virus type 2)
Boehringer Ingelheim (Canada)
Boehringer Ingelheim (Canada)
Affinity DataIC50: 38nMpH: 5.5 T: 2°CAssay Description:Sensitivity of HIV-1 protease activity to protease inhibitors was determined by a peptide substrate cleavage assay. Cleavage products and substrate w...More data for this Ligand-Target Pair
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Boehringer Ingelheim (Canada)
Boehringer Ingelheim (Canada)
Affinity DataIC50: 39nMpH: 5.5 T: 2°CAssay Description:Sensitivity of HIV-1 protease activity to protease inhibitors was determined by a peptide substrate cleavage assay. Cleavage products and substrate w...More data for this Ligand-Target Pair
TargetDimer of Gag-Pol polyprotein [514-612](Human immunodeficiency virus type 2)
Boehringer Ingelheim (Canada)
Boehringer Ingelheim (Canada)
Affinity DataIC50: 42nMpH: 5.5 T: 2°CAssay Description:Sensitivity of HIV-1 protease activity to protease inhibitors was determined by a peptide substrate cleavage assay. Cleavage products and substrate w...More data for this Ligand-Target Pair
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Boehringer Ingelheim (Canada)
Boehringer Ingelheim (Canada)
Affinity DataIC50: 50nMpH: 5.5 T: 2°CAssay Description:Sensitivity of HIV-1 protease activity to protease inhibitors was determined by a peptide substrate cleavage assay. Cleavage products and substrate w...More data for this Ligand-Target Pair
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Boehringer Ingelheim (Canada)
Boehringer Ingelheim (Canada)
Affinity DataIC50: 58nMpH: 5.5 T: 2°CAssay Description:Sensitivity of HIV-1 protease activity to protease inhibitors was determined by a peptide substrate cleavage assay. Cleavage products and substrate w...More data for this Ligand-Target Pair
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Boehringer Ingelheim (Canada)
Boehringer Ingelheim (Canada)
Affinity DataIC50: 62nMpH: 5.5 T: 2°CAssay Description:Sensitivity of HIV-1 protease activity to protease inhibitors was determined by a peptide substrate cleavage assay. Cleavage products and substrate w...More data for this Ligand-Target Pair
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Boehringer Ingelheim (Canada)
Boehringer Ingelheim (Canada)
Affinity DataIC50: 125nMpH: 5.5 T: 2°CAssay Description:Sensitivity of HIV-1 protease activity to protease inhibitors was determined by a peptide substrate cleavage assay. Cleavage products and substrate w...More data for this Ligand-Target Pair
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Boehringer Ingelheim (Canada)
Boehringer Ingelheim (Canada)
Affinity DataIC50: 135nMpH: 5.5 T: 2°CAssay Description:Sensitivity of HIV-1 protease activity to protease inhibitors was determined by a peptide substrate cleavage assay. Cleavage products and substrate w...More data for this Ligand-Target Pair
TargetDimer of Gag-Pol polyprotein [514-612](Human immunodeficiency virus type 2)
Boehringer Ingelheim (Canada)
Boehringer Ingelheim (Canada)
Affinity DataIC50: 135nMpH: 5.5 T: 2°CAssay Description:Sensitivity of HIV-1 protease activity to protease inhibitors was determined by a peptide substrate cleavage assay. Cleavage products and substrate w...More data for this Ligand-Target Pair
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Boehringer Ingelheim (Canada)
Boehringer Ingelheim (Canada)
Affinity DataIC50: 140nMpH: 5.5 T: 2°CAssay Description:Sensitivity of HIV-1 protease activity to protease inhibitors was determined by a peptide substrate cleavage assay. Cleavage products and substrate w...More data for this Ligand-Target Pair
TargetDimer of Gag-Pol polyprotein [514-612](Human immunodeficiency virus type 2)
Boehringer Ingelheim (Canada)
Boehringer Ingelheim (Canada)
Affinity DataIC50: 185nMpH: 5.5 T: 2°CAssay Description:Sensitivity of HIV-1 protease activity to protease inhibitors was determined by a peptide substrate cleavage assay. Cleavage products and substrate w...More data for this Ligand-Target Pair
Affinity DataIC50: 760nMAssay Description:Compound was for its ability to displace [3H]-haloperidol binding to rat striatal Dopamine receptor D2More data for this Ligand-Target Pair
Affinity DataIC50: 880nMAssay Description:Compound was for its ability to displace [3H]-haloperidol binding to rat striatal Dopamine receptor D2More data for this Ligand-Target Pair
Affinity DataIC50: 1.05E+3nMAssay Description:Compound was for its ability to displace [3H]-haloperidol binding to rat striatal Dopamine receptor D2More data for this Ligand-Target Pair
Affinity DataIC50: 1.07E+3nMAssay Description:Compound was for its ability to displace [3H]-haloperidol binding to rat striatal Dopamine receptor D2More data for this Ligand-Target Pair
Affinity DataIC50: 1.09E+3nMAssay Description:Ability to displace [3H]WB-4101 from rat brain alpha-1 adrenergic receptorMore data for this Ligand-Target Pair
Affinity DataIC50: 1.20E+3nMAssay Description:Compound was for its ability to displace [3H]-haloperidol binding to rat striatal Dopamine receptor D2More data for this Ligand-Target Pair
Affinity DataIC50: 1.44E+3nMAssay Description:Ability to displace [3H]WB-4101 from rat brain alpha-1 adrenergic receptorMore data for this Ligand-Target Pair
Affinity DataIC50: 1.50E+3nMAssay Description:Compound was for its ability to displace [3H]-haloperidol binding to rat striatal Dopamine receptor D2More data for this Ligand-Target Pair
Affinity DataIC50: 2.20E+3nMAssay Description:Compound was for its ability to displace [3H]-haloperidol binding to rat striatal Dopamine receptor D2More data for this Ligand-Target Pair
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Boehringer Ingelheim (Canada)
Boehringer Ingelheim (Canada)
Affinity DataIC50: 4.85E+3nMpH: 5.5 T: 2°CAssay Description:Sensitivity of HIV-1 protease activity to protease inhibitors was determined by a peptide substrate cleavage assay. Cleavage products and substrate w...More data for this Ligand-Target Pair
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Boehringer Ingelheim (Canada)
Boehringer Ingelheim (Canada)
Affinity DataIC50: 8.25E+3nMpH: 5.5 T: 2°CAssay Description:Sensitivity of HIV-1 protease activity to protease inhibitors was determined by a peptide substrate cleavage assay. Cleavage products and substrate w...More data for this Ligand-Target Pair
Affinity DataIC50: 8.55E+3nMAssay Description:Compound was for its ability to displace [3H]haloperidol binding to rat striatal Dopamine receptor D2More data for this Ligand-Target Pair
Affinity DataIC50: 1.66E+4nMAssay Description:Compound was for its ability to displace [3H]-haloperidol binding to rat striatal Dopamine receptor D2More data for this Ligand-Target Pair
Affinity DataIC50: 9.00E+4nMAssay Description:Ability to displace [3H]WB-4101 from rat brain alpha-1 adrenergic receptorMore data for this Ligand-Target Pair
Affinity DataIC50: 9.40E+4nMAssay Description:Inhibition of bovine cardiac phosphodiesterase fraction IIIMore data for this Ligand-Target Pair